1. Home
  2. TRVI vs STUB Comparison

TRVI vs STUB Comparison

Compare TRVI & STUB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trevi Therapeutics Inc.

TRVI

Trevi Therapeutics Inc.

SELL

Current Price

$13.31

Market Cap

1.9B

Sector

Health Care

ML Signal

SELL

Logo StubHub Holdings Inc.

STUB

StubHub Holdings Inc.

SELL

Current Price

$4.93

Market Cap

2.3B

ML Signal

SELL

Company Overview

Basic Information
Metric
TRVI
STUB
Founded
2011
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Services-Misc. Amusement & Recreation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.3B
IPO Year
2019
2025

Fundamental Metrics

Financial Performance
Metric
TRVI
STUB
Price
$13.31
$4.93
Analyst Decision
Strong Buy
Buy
Analyst Count
11
14
Target Price
★ $28.18
$9.21
AVG Volume (30 Days)
1.5M
★ 6.0M
Earning Date
11-09-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 31.91
N/A
EPS
N/A
★ 0.11
Revenue
N/A
★ $1,745,188,000.00
Revenue This Year
N/A
$14.78
Revenue Next Year
N/A
$8.28
P/E Ratio
★ N/A
$48.18
Revenue Growth
★ N/A
N/A
52 Week Low
$9.82
$5.03
52 Week High
$20.22
$16.63

Technical Indicators

Market Signals
Indicator
TRVI
STUB
Relative Strength Index (RSI) 46.10 35.20
Support Level $13.00 N/A
Resistance Level $13.55 $6.40
Average True Range (ATR) 0.88 0.39
MACD 0.06 -0.10
Stochastic Oscillator 20.92 0.85

Price Performance

Historical Comparison
TRVI
STUB

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.

About STUB StubHub Holdings Inc.

Stubhub Holdings Inc operates a ticketing marketplace for live events where fans can buy tickets from sellers of all types through its StubHub and viagogo websites and mobile applications. The company generates majority of its revenue from United States.

Share on Social Networks: